Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Fatigue 5 Breast Neoplasms 5 Anxiety Disorders 3 Lung Neoplasms 2 Uterine Neoplasms 1 Substance-Related Disorders 1 Sleep Wake Disorders 1 Sleep Initiation and Maintenance Disorders 1 Psychological Well-Being 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Pain 1 Ovarian Neoplasms 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neoplasm Regression, Spontaneous 1 Multiple Myeloma 1 Lymphoma 1 Leukemia 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Depression 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Chronic Pain 1 Caregiver Burden 1 Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Acceptance and Commitment Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cancer Recurrence × Acceptance and Commitment Therapy × Clear all

NCT01354041 2014-01-27

WiLLoW

University of California, San Francisco

Phase 1 Completed

Cancer Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡